#europcr
ORBITA-STAR at #EuroPCR is a fascinating & successful study of type of chest pain as a predictor of PCI success. Very difficult to ascertain if angina caused by ischemia is what patients felt. This was a concern of Gruentzig's 40 yrs ago! Christopher Rajkumar Rasha Al-Lamee #AngioHistory
Angioplasty.Org33,675 views • 2 years ago
In a trial of patients with bifurcation lesions, main branch stenting and POT, ending the procedure with no further intervention was noninferior to POT-side-POT or kissing balloon inflation for myocardial injury or infarction, and less likely required a second stent. #EuroPCR
PCRonline 🫀30,999 views • 3 years ago
Best session? Everyone had a different answer! Whatever you're looking for, find it in the Programme - just like Nicola Ryan Alessandro Beneduce Vincenzo Cesario Omar Oliva and Alessandro Sticchi did. 🔗 Register for #EuroPCR: 🗓️ 20-23 May 2025 | Paris #interventionalcardiology #CardioEd #MedEd #cardiology DrThomasCuisset nicolas dumonteil Nieves Gonzalo
PCRonline 🫀16,243 views • 1 year ago
Final MITRAL Trial 5Y outcomes LBCT @ #EuroPCR 2023. MViV, MViR & ViMAC with Sapien 3 was associated with sustained improvement of HF symptoms & QoL @ 5 years. THV function remained stable in all groups. Excellent survival @ 5 years in MViV, lower in MViR & ViMAC. Mayo Clinic CV
Mayra Guerrero, MD20,028 views • 3 years ago
I've been thinking a lot about what the three most significant trials could be for my practice among the many presented this year at #EuroPCR. In general, I prefer it when the primary endpoint is presented for the first time. This is my selection, feel free to disagree.
Davide Capodanno19,284 views • 3 years ago
No more content to load